Change - Announcement of Appointment::Announcement of Appointment of Chief Operating Officer

Issuer & Securities

Issuer/ Manager
LIVINGSTONE HEALTH HOLDINGS LIMITED
Securities
LIVINGSTONE HEALTH HLDGS LTD - SGXE70643320 - PRH
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
05-Feb-2021 00:43:01
Status
New
Announcement Sub Title
Announcement of Appointment of Chief Operating Officer
Announcement Reference
SG210205OTHRX829
Submitted By (Co./ Ind. Name)
Teh Wing Kwan
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Announcement of Appointment of Chief Operating Officer

This announcement has reviewed by the Company's sponsor, SAC Capital Private Limited ("Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Tay Sim Yee, SAC Capital Private Limited at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542, Telephone (65) 6232 3210.

Additional Details

Date Of Appointment
04/02/2021
Name Of Person
Lim Pang Yen Rachel
Age
39
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Board of Directors, having considered and reviewed the qualifications, working experience and suitability of Dr. Lim Pang Yen Rachel ("Dr. Rachel Lim"), is of the view that Dr. Rachel Lim has the requisite experience and capability to assume the responsibility Chief Operating Officer of the Company.

Accordingly, the Board of Directors approved the appointment of Dr. Rachel Lim as Chief Operating Officer of the Company.
Whether appointment is executive, and if so, the area of responsibility
Executive, Chief Operating Officer
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Professional qualifications
1. Certificate of Completion (IMSA Workshop in Singapore Botulinum Toxin Master Class) at International Microaesthetic Surgery Association
2. Certificate of Attendance (MyFace Cadaveric Workshop) at Academia, Singapore General Hospital
3. Certificate of Attendance (Combination Approach Symposium) at Merz Asia Pacific Pte. Ltd.
4. Certificate of Attendance (Devices for Skin Tightening) at Aesthetic Dermatology Educational Group
5. Certificate of Completion (IMSA Workshop in Taiwan Botulinum Toxin Master Class) at International Microaesthetic Surgery Association
6. Certificate of Attendance (Unlocking the MD Codes to V-Shape Face: Youth to Maturity) at Allergan Medical Europe Africa Middle East
7. Certificate of Participation (Optimising the Vycross Technology Combination Aesthetic Procedures) at Asian College of Aesthetic & Regenerative Medicine
8. Certificate of Attendance (Lasers (Ablative) for Skin Resurfacing) at Aesthetic Dermatology Educational Group
9. Certificate of Attendance (Chemical Peels) at Aesthetic Dermatology Educational Group
10. Certificate of Attendance (Skin Rejuvenation (Fractional Lasers)) at Aesthetic Dermatology Educational Group
11. Certificate of Competence (Laser Hair Removal Workshop) at Dermatological Society of Singapore and National Skin Centre
12. Certificate of Competence (Botulinum Toxin Workshop) at Dermatological Society of Singapore and National Skin Centre
13. Certificate of Competence (Derma Fillers Workshop) at Dermatological Society of Singapore and National Skin Centre
14. Certificate of Attendance (Intense Pulsed Light) at Aesthetic Dermatology Educational Group
15. Certificate of Attendance (Lasers for Treating Skin Pigmentation) at Aesthetic Dermatology Educational Group
16. Graduate Diploma in Family Medicine at National University of Singapore
17. Bachelor of Medicine and Bachelor of Surgery at National University of Singapore
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Yes. Dax Ng, the Chief Business Officer of the Company, is Dr. Rachel Lim's brother-in-law.

Dr. Rachel Lim has a 17.35% direct interest in Livingstone Health Consolidated Pte. Ltd., a controlling shareholder holding approximately 215,311,056 shares in the Company.
Conflict of interests (including any competing business)
Dr. Rachel Lim is employed as the Chief Operating Officer and a medical doctor of the Group.

Dr. Rachel Lim is a shareholder of VS Investment Holdings Pte. Ltd. Dr. Sean Ng, spouse of Dr. Rachel Lim, carried out his orthopaedic medical practice under VS Investment Holdings (formerly known as Ardmore Orthopaedics Pte. Ltd.). Pursuant to the business transfer to the LSH Group, the company is an investment holding company and is holding onto a property and collects rental income.

Dr. Rachel Lim is a director and shareholder of VS Venture Pte. Ltd. She previously carried out one (1) of her aesthetics businesses under VS Venture Pte. Ltd.. The company has been gazetted to be struck off.

Dr. Rachel Lim was a director and shareholder of Ardmore Wellness (Novena) Pte. Ltd. Ardmore Wellness (Novena) Pte. Ltd. has been struck off.
Working experience and occupation(s) during the past 10 years
1. January 2020 - Present: Chief Operating Officer at Livingstone Health Ltd.
2. December 2018 - January 2020: Chief Marketing Officer at Livingstone Health Ltd.
3. July 2015 - Present: Family Physician at RL Aesthetics Pte. Ltd.
4. July 2015 - Present: Family Physician at Cove Wellness Pte. Ltd.
5. May 2014 - June 2015: Family Physician at ClearSkin Centre Pte. Ltd.
6. January 2014 - May 2014: Family Physician at Prive Clinic Pte. Ltd.
7. July 2013 - November 2013: Family Physician at Eastlife Pte. Ltd.
8. June 2012 - June 2013: Resident Physician at Healthway Medical Group Pte. Ltd.
9. June 2005 - May 2011: Medical Officer and House Officer at MOH Holdings Pte. Ltd.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Directorships
Ardmore Wellness (Novena) Pte. Ltd.

Other Principal Commitments
None
Present
Directorships
Livingstone Soriya Medical Specialist Co., Ltd.
Cove Wellness Pte. Ltd.
Livingstone Health International Pte. Ltd.
RL Aesthetics Pte. Ltd.
VS Venture Pte. Ltd. (formerly Ardmore Aesthetics (Novena) Pte. Ltd.)

Other Principal Commitments
None
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not Applicable
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not Applicable